Atossa Therapeutics, Inc. 

WA

  SEC # 1488039

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Relationships

        

No  Owner Relationships  (where the Issuers of the  Atossa Therapeutics, Inc.-owned  securities are...)

        

First  20  of  44  Issuer Relationships  (where the Owners of the  Atossa Therapeutics, Inc.  securities are...)

First		Latest Filing		Filing		Filer / Owner
11/15/23		4/11/24		4		VA	Finn Jonathan
		3/14/24		3		WA	Cigler Tessa
		3/14/24		4			"
10/15/13		11/17/23		4		CA	Weaver Gregory L
		11/15/23		3		VA	Finn Jonathan
		10/16/23		3		WA	Rees Heather
3/13/13		5/5/23		4		WA	Chen Shu-Chih
5/9/13		5/5/23		4		WA	Galli Stephen J
1/9/13		5/5/23		4		WA	Remmel H. Lawrence
3/4/14		5/5/23		4		CT	Steinhart Richard I
6/6/13		3/6/23		4		WA	Guse Kyle
3/13/13		3/6/23		4		WA	Quay Steven C
2/9/22		2/9/23		SC 13G		PA	Vanguard Group Inc.
2/4/22		7/8/22		SC 13G		NY	BlackRock Inc.
12/18/20		2/14/22		SC 13G			CVI Investments, Inc.
10/31/17		1/13/22		SC 13G		NY	Empery Asset Management, LP
4/27/18		1/15/21		SC 13G		FL	Intracoastal Capital, LLC
11/9/17		2/14/18		SC 13G		NY	Iroquois Capital Management, LLC
		11/3/17		SC 13G			L1 Capital Global Opportunities Master Fund, Ltd.
11/16/12		1/28/16		SC 13D		WA	Quay Steven C
→Please Sign In to List all of them.

List all Money Managers that own this Security Issuer:  CUSIP 04962H

        

First  20  of  31  Insider & Control Relationships  (Directors & Officers, Owners, Parent / Subs., et al.)

First		Latest Filing		Relationship		Registrant
11/15/23		4/11/24		Director		VA	Finn Jonathan
		3/14/24		Director		WA	Cigler Tessa
		11/17/23		Officer:  Former EVP, CFO, & Director		CA	Weaver Gregory L
10/15/13		11/17/23		Director			"
		10/16/23		Officer:  SVP, Finance & Accounting		WA	Rees Heather
6/5/23		6/20/23		Officer:  EVP & CFO		CA	Weaver Gregory L
11/7/12		5/5/23		Director		WA	Chen Shu-Chih
11/7/12		5/5/23		Director		WA	Galli Stephen J
11/7/12		5/5/23		Director		WA	Remmel H. Lawrence
3/4/14		5/5/23		Director		CT	Steinhart Richard I
5/19/16		3/6/23		Officer:  CFO, Gen Counsel & Secretary		WA	Guse Kyle
3/18/15		3/6/23		Officer:  President & CEO		WA	Quay Steven C
11/7/12		3/6/23		Director			"
11/7/12		5/19/16		10% Owner		WA	Chen Shu-Chih
11/7/12		5/19/16		10% Owner		WA	Quay Steven C
		9/3/15		Officer:  Chief Operating Officer		WA	Youmans Scott
		3/18/15		Officer:  SVP, Sales & Marketing		WA	Destro Christopher S.
		3/18/15		Officer [ see Filing ]		WA	Guse Kyle
		3/18/15		Officer [ see Filing ]		WA	Sawyer John E
		6/6/14		Officer:  Senior Vice President			"
→Please Sign In to List all of them.

        

No  Joint-Filer Relationships  (Co-Filer Registrants:  Partners, Affiliates, et al.)

        

No  Group-Member Relationships  (Co-Filer Non-Registrants:  Partners, Affiliates, et al.)

        

Filing Agent Relationships  (SEC Filing Agents, Attorneys, Printers, et al. — Affiliates:  Directors & Officers, et al.)

9  Filing Agents and/or Registrants have submitted Filings for  Atossa Therapeutics, Inc.:

Latest Filing				Filing Agentª, Registrant or SEC — SEC #			Filings
		Type
4/1/24		8-K/A		FL	Donnelley Financial Solutions/FA — 950170		5
11/13/23		10-Q		VA	RDG Filings/FA — 1437749		111
4/30/21		EFFECT			No Filing Agent:  SEC-filed by SEC #5 — 9999999995		19
11/13/18		10-Q/A			S2 Filings LLC/FA — 1615774		66
2/13/17		S-1		NY	Toppan Merrill/FA — 1144204		158
4/11/13		D			Western Asset Real Alpha Portfolio, Ltd. — 1551333		1
11/14/12		CT ORDER			No Filing Agent:  SEC-filed by SEC #7 — 9999999997		2
6/23/11		D/A			No Filing Agent:  Self-filed — 1488039		3
5/13/11		D		NY	Alphakeys Millennium Fund II, L.L.C. — 1519810		1
Total:							366
__________  ª  Proprietary to SEC Info℠:  The SEC does not publish the names of SEC Filing Agents.